Ozempic maker unveils new weight loss pill TWICE as good as its blockbuster jab - sending company's value rocketing above Tesla's

Novo Nordisk has revealed preliminary study results showing that its weight loss pill performed better than blockbuster shots. The company is now more valuable than Tesla and Visa at $566 billion.

Source: the Mail online | Health - March 7, 2024 Category: Consumer Health News Source Type: news